Atlas Trials

Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

Clinical trial NCT00640809 · COMPLETED

Trial details

NCT number
NCT00640809
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Bowel Diseases, Inflammatory
Start date
2003-10-01
Enrollment
408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.